<DOC>
	<DOCNO>NCT02767271</DOCNO>
	<brief_summary>The objective study evaluate pharmacokinetics Luliconazole Cream 1 % subject moderate severe tinea pedis tinea cruris .</brief_summary>
	<brief_title>Maximal Use Luliconazole Cream 1 % Pediatric Patients With Moderate Severe Tinea Pedis Tinea Cruris</brief_title>
	<detailed_description>The objective study evaluate pharmacokinetics Luliconazole Cream 1 % , measure circulate plasma level luliconazole , maximal quantity Luliconazole Cream 1 % applied patient 12 year &lt; 18 year age moderate severe inter-digital tinea pedis tinea cruris .</detailed_description>
	<mesh_term>Tinea</mesh_term>
	<mesh_term>Tinea Pedis</mesh_term>
	<criteria>Key Subjects ( legal guardian ) ability willingness sign write informed consent Subjects either gender least 12 year &lt; 18 year old ( 12 17 year , inclusive ) Subjects mycological diagnosis tinea pedis tinea cruris confirm detection fungal hypha microscopic KOH wet mount Subjects ability willingness follow study procedure , attend schedule visit , blood draw , successfully complete study Subjects must good general health free disease Investigator 's opinion might interfere study evaluation . Subjects must able communicate , able understand study procedure , willing comply study requirement . Key Subjects tinea pedis tinea cruris . Subjects active atopic contact dermatitis treatment area . Female subject pregnant and/or nurse plan pregnancy course trial . Subjects test positive pregnancy start test treatment discontinue test treatment follow safety purpose . Subjects immunocompromised ( due disease , e.g. , HIV medication ) . Subjects recent history current drug alcohol abuse .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>